Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

NYSE:EXK - New York Stock Exchange, Inc. - CA29258Y1034 - Common Stock - Currency: USD

3.98  +0.02 (+0.51%)

After market: 4.02 +0.04 (+1.01%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXK. EXK was compared to 151 industry peers in the Metals & Mining industry. EXK has a medium profitability rating, but doesn't score so well on its financial health evaluation. EXK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
In the past year EXK had a positive cash flow from operations.
EXK had positive earnings in 4 of the past 5 years.
EXK had a positive operating cash flow in 4 of the past 5 years.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.82%, EXK is in line with its industry, outperforming 41.06% of the companies in the same industry.
EXK has a Return On Equity of -7.13%. This is comparable to the rest of the industry: EXK outperforms 41.72% of its industry peers.
The Return On Invested Capital of EXK (1.32%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for EXK is significantly below the industry average of 8.54%.
Industry RankSector Rank
ROA -4.82%
ROE -7.13%
ROIC 1.32%
ROA(3y)2.53%
ROA(5y)-4.24%
ROE(3y)3.14%
ROE(5y)-5.8%
ROIC(3y)3.14%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

1.3 Margins

In the last couple of years the Profit Margin of EXK has grown nicely.
EXK has a Operating Margin (3.98%) which is in line with its industry peers.
Looking at the Gross Margin, with a value of 17.57%, EXK is in line with its industry, outperforming 55.63% of the companies in the same industry.
EXK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 17.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y50.95%
PM growth 5YN/A
GM growth 3Y-3.31%
GM growth 5Y50.27%
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
The number of shares outstanding for EXK has been increased compared to 5 years ago.
Compared to 1 year ago, EXK has an improved debt to assets ratio.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.78 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.78, EXK is in line with its industry, outperforming 58.94% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that EXK is not too dependend on debt financing.
EXK has a Debt to Equity ratio of 0.20. This is comparable to the rest of the industry: EXK outperforms 49.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 2.78
ROIC/WACC0.14
WACC9.39%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.39 indicates that EXK should not have too much problems paying its short term obligations.
The Current ratio of EXK (1.39) is worse than 71.52% of its industry peers.
A Quick Ratio of 1.07 indicates that EXK should not have too much problems paying its short term obligations.
EXK has a worse Quick ratio (1.07) than 61.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.07
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -280.00%.
The Earnings Per Share has been growing by 25.99% on average over the past years. This is a very strong growth
Looking at the last year, EXK shows a decrease in Revenue. The Revenue has decreased by -4.65% in the last year.
EXK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.42% yearly.
EPS 1Y (TTM)-280%
EPS 3Y25.99%
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y14.05%
Revenue growth 5Y6.42%
Sales Q2Q%8.11%

3.2 Future

The Earnings Per Share is expected to grow by 77.69% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXK will show a quite strong growth in Revenue. The Revenue will grow by 15.41% on average per year.
EPS Next Y-840.68%
EPS Next 2Y213%
EPS Next 3Y162.95%
EPS Next 5Y77.69%
Revenue Next Year7.97%
Revenue Next 2Y29.95%
Revenue Next 3Y30.67%
Revenue Next 5Y15.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 20.31 indicates a rather expensive valuation of EXK.
EXK's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. EXK is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 20.31
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

EXK's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.47
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

EXK's earnings are expected to grow with 162.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y213%
EPS Next 3Y162.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENDEAVOUR SILVER CORP

NYSE:EXK (3/7/2025, 8:22:43 PM)

After market: 4.02 +0.04 (+1.01%)

3.98

+0.02 (+0.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-07 2025-05-07
Inst Owners44.52%
Inst Owner Change25.35%
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.04B
Analysts78
Price Target5.77 (44.97%)
Short Float %5.35%
Short Ratio1.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1100.04%
Min EPS beat(2)-1981.29%
Max EPS beat(2)-218.79%
EPS beat(4)1
Avg EPS beat(4)-611.97%
Min EPS beat(4)-1981.29%
Max EPS beat(4)149.51%
EPS beat(8)1
Avg EPS beat(8)-354.44%
EPS beat(12)2
Avg EPS beat(12)-292.24%
EPS beat(16)4
Avg EPS beat(16)-220.21%
Revenue beat(2)2
Avg Revenue beat(2)3.68%
Min Revenue beat(2)0.81%
Max Revenue beat(2)6.54%
Revenue beat(4)4
Avg Revenue beat(4)5.84%
Min Revenue beat(4)0.81%
Max Revenue beat(4)14.94%
Revenue beat(8)6
Avg Revenue beat(8)2.82%
Revenue beat(12)7
Avg Revenue beat(12)-0.55%
Revenue beat(16)8
Avg Revenue beat(16)-2.27%
PT rev (1m)-1.06%
PT rev (3m)-4.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.93%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.31
P/S 4.62
P/FCF N/A
P/OCF 34.04
P/B 2.53
P/tB 2.53
EV/EBITDA 26.47
EPS(TTM)-0.09
EYN/A
EPS(NY)0.2
Fwd EY4.92%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)0.12
OCFY2.94%
SpS0.86
BVpS1.57
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.82%
ROE -7.13%
ROCE 1.68%
ROIC 1.32%
ROICexc 1.48%
ROICexgc 1.48%
OM 3.98%
PM (TTM) N/A
GM 17.57%
FCFM N/A
ROA(3y)2.53%
ROA(5y)-4.24%
ROE(3y)3.14%
ROE(5y)-5.8%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)4.47%
ROICexc(5y)N/A
ROICexgc(3y)4.47%
ROICexgc(5y)N/A
ROCE(3y)3.98%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y50.95%
PM growth 5YN/A
GM growth 3Y-3.31%
GM growth 5Y50.27%
F-Score2
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 2.02
Cap/Depr 605.27%
Cap/Sales 84.52%
Interest Coverage 4.44
Cash Conversion 75.65%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.07
Altman-Z 2.78
F-Score2
WACC9.39%
ROIC/WACC0.14
Cap/Depr(3y)350.08%
Cap/Depr(5y)241.35%
Cap/Sales(3y)47.42%
Cap/Sales(5y)35.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280%
EPS 3Y25.99%
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y-840.68%
EPS Next 2Y213%
EPS Next 3Y162.95%
EPS Next 5Y77.69%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y14.05%
Revenue growth 5Y6.42%
Sales Q2Q%8.11%
Revenue Next Year7.97%
Revenue Next 2Y29.95%
Revenue Next 3Y30.67%
Revenue Next 5Y15.41%
EBIT growth 1Y-59.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-42.27%
EBIT Next 3Y91.14%
EBIT Next 5Y46.51%
FCF growth 1Y-135.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.96%
OCF growth 3Y-32.9%
OCF growth 5Y-15.08%